| Date | Title | Description |
| 18.10.2023 | The Ridiculous Edge Companies Gain By Doubling Down On Company Culture Early | Most companies don’t get serious about leadership development until it’s nearly too late. They grow ... [+] quickly and when they finally put in the work to scale and sustain the culture of their company, it’s an uphill battle.getty |
| 28.07.2022 | Syapse Raises $35M in Growth Funding | Syapse, a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding.
The round was led by Innovatus Capital Partners, with participation from existing investors including All... |
| 27.07.2022 | Syapse Raises $35M to Expand Learning Health Network | What You Should Know:
– Syapse raises $35M led by an affiliate of Innovatus Capital Partners, LLC (Innovatus)to tackle the challenge of understanding, preventing, and treating complex cancers.
– The investment will allow Syapse to expand it... |
| 27.07.2022 | Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network | SAN FRANCISCO and NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced the closing of a $... |
| 21.04.2022 | Using NLP Technology To Uncover Real-World Patient Insights | It’s estimated that humans create a combined 2.5 quintillion bytes of data each day – and that around 90% of all data to ever exist was created in just the last few years. As difficult as it is to ignore the massive impact that connected te... |
| 20.01.2022 | Syapse, Pfizer Extends Collaboration to Generate Real-World Evidence in Breast Cancer | What You Should Know:
– Syapse, a real-world evidence company that informs cancer care, announced that it will extend its collaboration with Pfizer to generate real-world evidence in breast cancer.
– This is the third phase of the collabora... |
| 05.01.2022 | Illumina and Syapse Partner on Biomarker Testing Research Across Oncology Practices | What You Should Know:
– Syapse, a real-world evidence company that informs cancer care, announced a partnership with Illumina aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community onc... |
| 06.12.2021 | Syapse Announces New Studies Published at Virtual ISPOR Europe 2021 | Each study utilized real-world data from the Syapse Learning Health Network™ to draw insights that inform real-world practice patterns and improve future research and clinical care
SAN FRANCISCO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a... |
| 03.02.2021 | Syapse Announces $68 Million Strategic Investment with Ally Bridge Group and Northpond Ventures to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network | February 02, 2021 10:00 ET
— Financing to support expanded partnering opportunities with life sciences, health systems, regulators and molecular labs —
— Syapse committed to delivering real-world insights to improve outcomes for people wi... |
| 02.02.2021 | Syapse Lands $68M to Expand Global Precision Oncology Data Sharing Network | What You Should Know:
– Syapse raises 68M in equity investment led by Ally Bridge Group (ABG), with Northpond Ventures to expand delivery of real-world evidence through Syapse’s Learning Health Network.
– The Syapse Learning Health Network ... |
| 04.01.2021 | Genetic testing company Color raises $167M to roll out COVID vaccines | The company partnered with state and local governments to power their COVID testing initatives
COVID is going to have a profound effect on the healthcare space; some of those effects are showing themselves, such as with the rise of teleheal... |
| 06.10.2020 | The role of precision medicine in the pandemic response | Investments into precision medicine companies is rising, but how much has it helped?
What healthcare will look like when the COVID pandemic is over is tough to say right now. What new technologies will emerge from this? What new data sets a... |
| 08.09.2020 | What are tips for increasing employee engagement and productivity virtually? | Remote work can be lonely. It can be stressful. Employers need to adapt.
In the last decade, the number of Americans working from home, at least some of the time, more than doubled — accelerating after 2005. Then the pandemic thrust nearly ... |
| 28.05.2020 | Syapse Lands $30M to Accelerate Real-World Evidence in Oncology | What You Should Know:
– Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
– Syapse partners with health systems, life sciences companies, and... |
| 23.07.2019 | Syapse, Pfizer enter deal to develop precision medicine in oncology | “Pfizer is on the forefront of utilizing real-world data to improve the lives of patients worldwide, and we are pleased to work with them to unlock evidence and insights that can help improve patient care and accelerate the availability of ... |
| 31.05.2018 | Improving the patient experience: The next frontier in health tech | There are certainly healthcare technology companies that are making a meaningful difference for patients by making the system more precise, faster, more accurate, more convenient and respectful of the real world in which people live as regu... |
| 22.05.2018 | For cancer patients, Trump’s drug pricing proposal falls short | President Trump’s long-awaited plan to reduce the costs of prescription drugs calls for a comprehensive set of reforms, including redesigning the patent system to prevent drug monopolies, uncloaking the role of pharmacy benefit managers, an... |
| 26.04.2018 | This $300M fund wants to help precision medicine startups blast off | Thought still nascent, the precision medicine industry is projected to hit the $141 billion mark by 2026. A new $300 million venture capital fund is looking to help companies in the personalized devices and medical practices space innovativ... |
| 01.03.2018 | Meet Scott Barclay, Investing Partner at Data Collective | An investor in sci-fi-like digital health looks to revolutionize 'failed' healthcare system
As entrepreneurship has become a global meme, with the title of "Founder" worn like a badge of accomplishment, there's no shortage of emer... |
| 23.02.2018 | San Francisco’s Syapse expands Philly-area office in play for tech talent | For Syapse, a San Francisco–based health IT company, the initial draw to the Philly area began in 2014 when Safeguard Scientifics led its $10 million Series B.
At the time, the company set up its first presence with a small outpost at Safeg... |
| 17.11.2017 |
Amgen Ventures Backs Syapse In $30M Precision Oncology Funding
| Amgen Ventures, the venture investment arm of Thousand Oaks-based Amgen, is one of the new investors in precision oncology and medicine startup Syapse. Syapse said this week that it raised $30M in a Series D funding round, which came from A... |
| 14.11.2017 | Term Sheet — Tuesday, November 14 | THREE THINGS
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
• A DFJ spokesperson told me Jurvetson left “by mutual agreement.”
• Meanwhile, Jurvetson tweeted that he’s leaving the fir... |
| 14.11.2017 | Syapse raises a $30M Series D round to scale its precision medicine program | CEO Ken Tarkoff said the money “is largely for expansion purposes,” which he stressed did not just mean signing new customers. The company also wants to improve its precision oncology programs for existing hospital partners. They include In... |
| 14.11.2017 | Syapse Lands $30M to Expand Precision Oncology to More Healthcare Providers | Syapse, a a San Francisco, CA-based provider of precision oncology solutions, has raised $30 million in Series D financing. Participants include existing investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, S... |
| 14.11.2017 | Syapse Inks $30M Series D Funding |
SAN FRANCISCO, CA, Syapse, a leader in precision medicine solutions, has raised $30 million in Series D financing, which will enable more healthcare providers to use precision medicine to improve care for their cancer patients.
>> ... |
| 14.11.2017 | Syapse Raises $30M in Series D Funding | Syapse, a San Francisco, CA-based developer of precision medicine solutions, raised $30m in Series D financing.
Participants included existing investors Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Sc... |
| 14.11.2017 | Precision medicine startup Syapse raises $30 million to expand cancer tech, S.F. workforce | - |
| 27.06.2017 | Syapse president: Precision medicine is the reality of cancer care | This exchange has been lightly edited.
Why is precision medicine the future of cancer care?
Precision medicine is providing better outcomes and better quality of life for advanced cancer patients today. That is why precision medicine is not... |
| 15.05.2017 | VC calls IBM Watson “a joke” | “Watson is a joke, just to be completely honest,” he said in an interview on CNBC’s “Closing Bell” last week.
Instead, he pointed to Google and Amazon as companies he would take seriously in the space, claiming they’re “head and shoulders a... |
| 06.04.2017 | Intermountain Healthcare Innovation Fund gives some more love to Redox | Healthbox has previously run an accelerator for healthcare startups called Healthbox Studio but with the management change last year, Healthbox repositioned itself as a venture capital investment manager with an innovation platform that fun... |
| 05.04.2017 | U of Miami Health System, Syapse join forces for cancer care | Sylvester Comprehensive Cancer Center, which is part of the University of Miami Health System, and Syapse, a Palo Alto, California-based software company, have teamed up to create a precision medicine initiative specifically focused on canc... |
| 12.01.2016 | Syapse Completes First Close of $25M Series C Funding | Syapse, a Palo Alto, California-based provider of precision medicine software, completed the first close of a $25m Series C funding round.
The round is being led by Ascension Ventures, a subsidiary of Ascension, the nation’s largest non-pro... |
| 12.01.2016 | Precision medicine software maker Syapse raises $25M | Patients, after all, are clamoring for precision medicine’s widespread adoption, Syapse President and Founder Jonathan Hirsch said in an interview at this week’s J.P. Morgan Healthcare Conference.
“They’re voting with their feet, choosing t... |
| 12.01.2016 | Daily funding roundup - January 12, 2016 | Skyscanner picked up $192M investments; Datadog raised $94.5M; Elastifile landed $35M funding
Gravit, a Berlin, Germany-based online vector design tool, raised a six digit seed funding. German investor High-Tech Gründerfonds (HTGF) made the... |
| 12.01.2016 | Syapse Raises $25 Million Series C Round Led by Ascension Ventures to Expand Precision Medicine | - |
| 12.01.2016 | Syapse Raises $25M to Transform Patient Care Through Precision Medicine | Syapse, a Palo Alto, CA-based company enabling healthcare systems to implement precision medicine programs has raised $25 million in Series C funding led by Ascension Ventures, a subsidiary of Ascension, the nation’s largest non-profit and ... |
| 09.10.2015 | No more guppies. 3 healthcare investors who would kill it on Shark Tank | There aren’t tons of Damons and Barbaras in healthcare. But there are a few. Here’s who I’d like to see tell someone, “I’m out” on a Friday night.
Chamath Palihapitiya, the founder and managing partner of Social + Capital Partnership, is pr... |
| 04.08.2015 | UCSF’s one-size-fits-all precision medicine test for infection | The project uses the work led by UCSF researcher Dr. Charles Chiu, who has developed a DNA sequencing scheme that can detect any pathogen with a single test. It’s already been tested a fair amount, and notably helped save the life of a 14-y... |
| 17.01.2015 | The biggest healthtech deals of 2014 | Categories include telemedicine, digital medical devices and personalized medicine
This month, in anticipation of Vator hosting its first ever Splash Health event on February 12th, we've been putting the spotlight on the healthtech space.
E... |
| 29.10.2014 | 10 startups show off their tech at HealthBeat's Innovation Showcase | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
SAN FRANCISCO — Ten of the most innovative startu... |
| 29.10.2014 | 10 startups show off their tech at HealthBeat's Innovation Showcase | SAN FRANCISCO — Ten of the most innovative startups in digital health demonstrated their products live on stage at VentureBeat’s HealthBeat conference yesterday.
Grilling the startups after their demos were venture capitalists Casper de Cle... |
| 29.10.2014 | Here’s a few of the health startups that stood out at HealthBeat | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| 23.10.2014 | Disrupt this: Announcing HealthBeat's 10 Innovation Showcase finalists | Spurred on by renewed investment in digital health and government health reform, hundreds of startups are now working to address friction points and broken systems within health care.
But only a select number of those startups will find the... |
| 06.10.2014 | Why this Safeguard Scientifics portfolio company opened a Philly office | Syapse, a Palo Alto, Calif.-based healthcare software provider and Safeguard Scientifics portfolio company, chose the Philadelphia region for its East Coast office.
It will initially work out of Safeguard’s Wayne office, Syapse CEO Glenn Wi... |
| 11.07.2014 | Funding Roundup - week ending 7/11/14 | GetYou, Google Ventures, Cover, jobandtalent, mNectar, HotelQuickly, DigitalOcean, Spectrum Equity
Seed stage
Social feedback platform GetYou raised a $1.1 million seed round from venture capital firm RDSeed and angel investors, including W... |
| 10.07.2014 | Syapse Raises $10M in Series B Financing | Syapse, a Palo Alto, CA-based developer of a Precision Medicine Data Platform, raised $10m in Series B financing.
The round was led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor The Social+Capital Partnership... |
| 10.07.2014 | Syapse raises $10M to power 'precision medicine' | Healthcare software provider Syapse has raised $10 million in a Series B round of financing, the company announced today.
Diseases such as cancer often require complex, precise care. Syapse is dedicated to improving how medical professional... |
| 10.07.2014 | Syapse Raises $10M Series B |
PALO ALTO, CA, Creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics.
>> Click here for more funding data on Syapse
>> To export Syap... |
| 10.07.2014 | Syapse raises $10M to power 'precision medicine' | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Healthcare software provider Syapse has raised $1... |
| 10.07.2014 | Funding Daily: The everything-gets-money edition | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Oh, my. Today was a huge day in the land of money... |
| 10.07.2014 | Health IT company that helps make sense of genomics data raises $10M | Syapse, a healthcare data analytics company that helps health systems crunch and analyze genomics data and clinical data to support treatment decisions has closed a Series B round. It will go toward expanding the company’s sales and marketi... |
| 22.01.2013 | Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund | The latest victory for the Palo Alto, California-based startup is closing a $3 million series A round led by The Social+Capital Partnership, a venture fund launched by former Facebook Vice President Chamath Palihapitiya. In its two years of... |
| 22.01.2013 | Funding Daily: Social media bling | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The internet was buzzing today with the shocking ... |
| 22.01.2013 | Genomics startup gets $3M to usher in new era of ‘personalized medicine’ | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
The cost of sequencing the human genome has plumm... |
| 22.01.2013 | Syapse Raises $3M From The Social+Capital Partnership To Bring Genomic Information To Everyday Healthcare | Founded at Stanford University in 2008, Syapse has been on a mission to help disrupt healthcare by incorporating “omics” (or the study of fields within biology typically ending in “-omics,” like genomics, proteomics or metabolomics, for exa... |
| 22.01.2013 | Syapse Snares Series A |
PALO ALTO, CA, Leader in bringing omics into routine medical use announced today that it has raised a Series A round of venture capital funding led by The Social+Capital Partnership.
>> Click here for more funding data on Syapse
&... |
| 22.01.2013 | Genomics startup gets $3M to usher in new era of ‘personalized medicine’ | The cost of sequencing the human genome has plummeted. But how will this benefit doctors and patients?
Biomedical researchers hope to harness data about the human gene pool to usher a new era of “personalized medicine,” which could lead to ... |
| 22.01.2013 | Syapse Raises Series A Venture Capital Funding | Syapse, a Palo ALto, CA-based developer of applications that enable the generation and use of omics profiles in diagnosing and treating patients, raised a Series A venture capital funding.
The round, whose amount was not disclosed, was led ... |
| - | No more guppies. 3 healthcare investors who would kill it on Shark Tank | Healthcare always gets a bad rap on Shark Tank. That the case even now, as the let’s-make-an-entrepreneur talent show begins cycling in guest investors in its seventh season. All we’re getting are Silicon Valley sycophants like Ashton Kuche... |
| - | Syapse president: Precision medicine is the reality of cancer care | Precision medicine holds great promise when it comes to solving healthcare’s greatest problems, and oncology is no exception. But with that hope comes numerous challenges.
Via email, Jonathan Hirsch, founder and president of San Francisco, ... |
| - | Syapse raises a $30M Series D round to scale its precision medicine program | It started off small. There was a low key $1.5 million seed round and then a $3 million Series A announced in 2013.
Fast-forward to 2017 and it’s clear Syapse is working on a much larger scale. On Tuesday, the Palo Alto, California-based so... |
| - | Intermountain Healthcare Innovation Fund gives some more love to Redox | Redox Engine, the Madison, Wisconsin health IT startup that’s helping healthcare facilities overcome interoperability challenges has received $1 million in follow-on investment from Intermountain Healthcare Innovation Fund, according to a c... |
| - | Health IT company that helps make sense of genomics data raises $10M | Syapse, a healthcare data analytics company that helps health systems crunch and analyze genomics data and clinical data to support treatment decisions has closed a Series B round. It will go toward expanding the company’s sales and marketi... |
| - | Improving the patient experience: The next frontier in health tech | This week I had the pleasure to give a talk about big data/AI and digital health (buzzword bingo alert) at the Stanford Big Data in Precision Health Conference in Palo Alto. While most of the very interesting speakers spoke about technology... |
| - | Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund | Sequencing the genome is one thing. Making sense of the data that generates is another.
That’s what Syapse Inc., self-proclaimed as “one of the largest repositories of human molecular profiles,” is helping laboratories and sequencing compan... |
| - | VC calls IBM Watson “a joke” | To the average American, artificial intelligence is something mesmerizing, something to be applauded. And IBM is supposedly on the forefront of the field.
But Chamath Palihapitiya, CEO and founder of Social Capital, a Palo Alto, California-... |
| - | Three Questions We’re Asking at the Intersection of Data Science and Human Health | Exploring the Intersection of Data Science & Human Health
Health data is more diverse, accessible, and useful than it has ever been. Technological advancements have transformed information about human health into digital form, enabling... |
| - | Syapse, Pfizer enter deal to develop precision medicine in oncology | A company that uses data from various sources for the development of precision medicine programs in oncology has gained its latest pharmaceutical industry partner.
San Francisco-based Syapse said Tuesday that it had signed a collaboration d... |
| - | U of Miami Health System, Syapse join forces for cancer care | Precision medicine.
The phrase doesn’t fall on unfamiliar ears in the healthcare world. But now it’s getting an extra bit of attention with the launch of a new partnership.
Sylvester Comprehensive Cancer Center, which is part of the Univers... |
| - | Precision medicine software maker Syapse raises $25M | Folding precision medicine into the broader healthcare system is a complex logistical challenge – there are countless moving pieces involved, such as integrating EHR records with complex genomic data and treatment information.
Palo Alto pre... |
| - | UCSF’s one-size-fits-all precision medicine test for infection | Is it a superbug? A parasite? How about a fungus? Diagnosing an acute infection is a time-pressured guessing game – with doctors often flummoxed over what pathogen is causing a patient’s rapidly declining health.
The University of Californi... |
| - | Here’s a few of the health startups that stood out at HealthBeat | As HealthBeat drew to a close, ten digital health startups took to the stage in an attempt to convince healthcare techies (healthies? hechies?) that they were all the next big thing disrupting the toughest problems with in an industry fraug... |
